Regulatory Roundup: Three Companies Working With FDA to Restore Depleted US Supplies of the Leukemia Drug Cytarabine - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: Three Companies Working With FDA to Restore Depleted US Supplies of the Leukemia Drug Cytarabine

ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

According to Bloomberg News, Hospira, Fresenius SE, and Boehringer Ingelheim GmbH are working with FDA to restore depleted US supplies of the leukemia drug cytarabine. FDA has reportedly found an offshore manufacturer of the product to temporarily import the injectable product while other manufacturers work to increase their production levels of the product to meet patient demand. There have been problems with obtaining the drug's primary ingredient and preventing crystals of dried medicine from forming in vials, according to the Bloomberg report.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here